bluebird bio, Inc.
MND PROMOTER CHIMERIC ANTIGEN RECEPTORS
Last updated:
Abstract:
The invention provides vector compositions for delivering improved adoptive T cell therapies.
Status:
Application
Type:
Utility
Filling date:
7 Aug 2020
Issue date:
4 Feb 2021